Vivet Therapeutics Appoints Eduardo Bravo as New Chairman of the Board

BioClin Therapeutics, Inc.,Completes $50 Million Series B Financing with Addition of New Investors

CorWave is set to receive about €3 million in financing through France’s Worldwide Innovation Challenge for its NovaPulse program, a mini-invasive solution for cardiac support

Lundbeck to acquire Prexton Therapeutics adding foliglurax in clinical phase II to its pipeline of innovative treatments for patients suffering from Parkinson’s disease

OxThera announces the randomization of the first patient into its phase III EPHEX study with Oxabact

AM-Pharma announces Phase II study results of recAP in sepsis-associated Acute Kidney Injury

Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis

Kala Pharmaceuticals Appoints Gregory Perry to Board of Directors and as Audit Committee Chair

Minoryx Therapeutics spins off SEE-Tx platform into new company, Gain Therapeutics

QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing